The Metadvice platform will positively impact highly complex areas of medicine where the body of new knowledge/data grows quickly and where there is complexity in decision making across diagnosis, treatment selection, management and prognosis.
Metadvice’s decision support engine can be used to develop CDS applications, and can function as either standalone or in the form of fully health system-integrated applications.
It digests knowledge across the literature and clinical spectrum, integrates physician and patient feedback, and provides actionable insights and clinical decisions to enable real precision medicine.
Cardiometabolic disease include conditions such as hypercholesterolaemia, hypertension and type 2 diabetes, where growing numbers of high-risk patients are placing a burden on global health systems, and for which better diagnostic and treatment approaches are needed.
Complex hematological cancers, such as Acute Myeloid Leukemia (AML), Multiple Myeloma, and Myelodysplastic Syndromes (MDS) where there is a growing range of therapies, which offer much better outcomes for patients, but are all expensive and place a high burden on health systems.